Preimplantation Genetics Diagnosis (PGD) Market is Estimated to Reach $140 Million by 2024, Says Variant Market Research

1
Preimplantation Genetics Diagnosis (PGD) Market
is Estimated to Reach 140 Million by 2024, Says
Variant Market Research
Geetanjali Raut SEO Executive Variant Market
Research
2
Preimplantation Genetics Diagnosis (PGD) Market

• Global Preimplantation Genetics Diagnosis (PGD)
  Market is estimated to reach 140 Million by
  2024 growing at a CAGR of 6.2 from 2016 to
  2024. Preimplantation genetics diagnosis (PGD) is
  a technique used for genetic profiling of embryos
  before implantation to identify genetic defects
  in embryos or even of oocytes.  It enables to
  identify defects in embryos and aids in selecting
  health embryos that are further used for
  implanting in the uterus. It reduces the
  frequency of unprompted abortion and doubles the
  chances of delivering genetically healthy
  baby. This technique can selectively avoid the
  passing of hereditary disorders that prevails in
  the family into a newborn baby. Currently, PGD is
  the only technique available which are used to
  avoid highly affected embryo before implantation.

3
Global Preimplantation Genetics Diagnosis (PGD)
Market Size and Forecast, 2015 - 2024 (US
Million)
4
Preimplantation Genetics Diagnosis (PGD) Market

• Declining fertility rate globally, development of
  advanced technologies in the field of genetic
  analysis, and growing occurrence of genetic
  disorders are the drivers boosting the growth of
  the global preimplantation genetics diagnosis
  market. Moreover, increasing rate in the adoption
  of IVF, and rising possibility of genetic
  abnormalities in embryos with progressing
  maternal age also supports the growth of the
  market. However, stringent government
  regulations, and social-economic concerns would
  severally hamper the adoption among end users.
  Furthermore, increasing RD and market expansion
  would provide future scope for the market in the
  coming years.
• Browse Complete Report_at_ https//www.variantmarketr
  esearch.com/report-categories/medical-devices/prei
  mplantation-genetics-diagnosis-market

5
Global Preimplantation Genetics Diagnosis (PGD)
market share by region, 2024 (value)
6
KEY TAKEAWAYS FROM THE REPORT

• The report will provide detailed analysis of
  Preimplantation Genetics Diagnosis (PGD) Market
  with respect to major segments such as test type,
  and geography
• The report will include the qualitative and
  quantitative analysis with market estimation over
  2015-2024 and compound annual growth rate (CAGR)
  between 2016 and 2024
• Comprehensive analysis of market dynamics
  including factors and opportunities will be
  provided in the report
• An exhaustive regional analysis of
  Preimplantation Genetics Diagnosis (PGD) Market
  has been included in the report
• Profile of the key players in the Preimplantation
  Genetics Diagnosis (PGD) Market will be provided,
  which include key financials, product services,
  new developments and business strategies

7
Scope of Preimplantation Genetics Diagnosis (PGD)
Market

• Test Type Segments
• Gender Selection
• Chromosomal Abnormalities
• Single Gene Disorders
• HLA Typing
• Aneuploidy
• X-Linked Diseases
• Other Test Types
• Geographical Segments
• North America
• U.S.
• Canada
• Mexico

8
TABLE OF CONTENT

• Chapter 1. Prefix     1.1. Market Scope   
   1.2. Report Description     1.3. Research
  Methodology           1.3.1 Primary Research   
         1.3.2 Secondary Research           1.3.3
  In-house Data Modeling
• Chapter 2. Executive Summary

9
Scope of Preimplantation Genetics Diagnosis (PGD)
Market

• Europe
• UK
• Germany
• France
• Others
• Asia Pacific
• India
• China
• Japan
• Others

10
Scope of Preimplantation Genetics Diagnosis (PGD)
Market

• RoW
• South America
• Middle East
• Africa

11
TABLE OF CONTENT

• Chapter 1 Prefix
• 1.1 Market Scope
• 1.2 Report Description
• 1.3 Research Methodology
• 1.3.1 Primary Research
• 1.3.2 Secondary Research
• 1.3.3 In-house Data Modeling
• Chapter 2 Executive Summary

12
TABLE OF CONTENT

• Chapter 3 Market Outline
• 3.1 Market Inclination, Trend, Outlook and
  Viewpoint
• 3.2 Market Share Analysis Companys
  Competitive Scenario
• 3.3 Market Dynamics
• 3.3.1 Drivers
• 3.3.1.1 Impact Analysis
• 3.3.2 Restraints
• 3.3.2.1 Impact Analysis
• 3.3.3 Opportunities
• .

13
TABLE OF CONTENT

• Chapter 6 Company Profiles
• 6.1 Abbott Laboratories
• 6.2 Natera, Inc.
• 6.3 PerkinElmer, Inc.
• 6.4 Illumina, Inc.
• 6.5 F. Hoffmann-La Roche AG
• 6.6 Thermo Fisher Scientific, Inc.
• 6.7 Agilent Technologies, Inc.
• 6.8 PerkinElmer, Inc.
• 6.9 Cooper Surgical, Inc.
• 6.10 Beijing Genomics Institute (BGI)

14
CONTACT US

• Michael Mendes
• Head - Sales
• Variant Market Research
• 649 Mission St, 5th Floor, San Francisco,
• CA 94105,United States.
• Tel [phone]
• Fax [phone]
• Email michael.mendes_at_variantmarketresearch.com
• Email help_at_variantmarketresearch.com
• Follow Us
• LinkedIn Facebook Twitter Google

15
Thank You.

• Follow us

Sample Request
Facebook
Twitter
Linkedin
Google
Source Variant Market Research